Sionna Therapeutics, Inc. (SION) Cash Flow Statement
Sionna Therapeutics, Inc. (SION) generated -$75.9M of operating cash flow over the twelve months to 2026-06-30, spent $291000 on capital expenditure and had free cash flow of -$76.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SIONSionna Therapeutics, Inc.Follow SION — free
—
Price chart with a free account
- Market cap
- 162.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | -52.8 | -66.3 | -75.9 | |
| Capital expenditure | 0.0 | 0.4 | -0.3 | |
| Free cash flow | -52.8 | -66.7 | -76.2 | |
| Stock-based compensation | 3.7 | 12.1 | — |
USD millions · SEC XBRL
Sionna Therapeutics, Inc. — questions
- What is Sionna Therapeutics, Inc.'s operating cash flow?
- -$75.9M over the twelve months to 2026-06-30.
- How much does Sionna Therapeutics, Inc. spend on capital expenditure?
- $291000 over the twelve months to 2026-06-30.
- What is Sionna Therapeutics, Inc.'s free cash flow?
- -$76.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Sionna Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.